Ionis Pharmaceuticals Stock Operating Margin
| IONS Stock | USD 37.62 1.59 4.06% |
Ionis Pharmaceuticals fundamentals help investors to digest information that contributes to Ionis Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Ionis Stock. The fundamental analysis module provides a way to measure Ionis Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ionis Pharmaceuticals stock.
| Last Reported | Projected for Next Year | ||
| Operating Profit Margin | (0.45) | (0.47) |
Ionis | Operating Margin |
Ionis Pharmaceuticals Company Operating Margin Analysis
Ionis Pharmaceuticals' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Ionis Pharmaceuticals Operating Margin | (1.25) % |
Most of Ionis Pharmaceuticals' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ionis Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ionis Operating Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Ionis Pharmaceuticals is extremely important. It helps to project a fair market value of Ionis Stock properly, considering its historical fundamentals such as Operating Margin. Since Ionis Pharmaceuticals' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ionis Pharmaceuticals' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ionis Pharmaceuticals' interrelated accounts and indicators.
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Ionis Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Ionis Pharmaceuticals has an Operating Margin of -1.2512%. This is 96.43% lower than that of the Biotechnology sector and 98.88% lower than that of the Health Care industry. The operating margin for all United States stocks is 77.29% lower than that of the firm.
Ionis Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ionis Pharmaceuticals' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ionis Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ionis Pharmaceuticals by comparing valuation metrics of similar companies.Ionis Pharmaceuticals is currently under evaluation in operating margin category among related companies.
Ionis Pharmaceuticals ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Ionis Pharmaceuticals' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Ionis Pharmaceuticals' managers, analysts, and investors.Environmental | Governance | Social |
Ionis Fundamentals
| Return On Equity | -0.98 | ||||
| Return On Asset | -0.0813 | ||||
| Profit Margin | (0.50) % | ||||
| Operating Margin | (1.25) % | ||||
| Current Valuation | 5.26 B | ||||
| Shares Outstanding | 145.96 M | ||||
| Shares Owned By Insiders | 0.86 % | ||||
| Shares Owned By Institutions | 99.14 % | ||||
| Number Of Shares Shorted | 8.75 M | ||||
| Price To Earning | 101.16 X | ||||
| Price To Book | 15.74 X | ||||
| Price To Sales | 7.72 X | ||||
| Revenue | 787.65 M | ||||
| Gross Profit | (257.87 M) | ||||
| EBITDA | (322.84 M) | ||||
| Net Income | (366.29 M) | ||||
| Cash And Equivalents | 2.04 B | ||||
| Cash Per Share | 14.36 X | ||||
| Total Debt | 1.45 B | ||||
| Debt To Equity | 2.00 % | ||||
| Current Ratio | 8.18 X | ||||
| Book Value Per Share | 2.03 X | ||||
| Cash Flow From Operations | (307.51 M) | ||||
| Short Ratio | 10.01 X | ||||
| Earnings Per Share | (2.67) X | ||||
| Price To Earnings To Growth | 25.70 X | ||||
| Target Price | 56.19 | ||||
| Number Of Employees | 927 | ||||
| Beta | 0.41 | ||||
| Market Capitalization | 5.49 B | ||||
| Total Asset | 2.99 B | ||||
| Retained Earnings | (1.8 B) | ||||
| Working Capital | 2.19 B | ||||
| Current Asset | 837 M | ||||
| Current Liabilities | 148.88 M | ||||
| Net Asset | 2.99 B |
About Ionis Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ionis Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ionis Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ionis Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Ionis Pharmaceuticals is a strong investment it is important to analyze Ionis Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ionis Pharmaceuticals' future performance. For an informed investment choice regarding Ionis Stock, refer to the following important reports: Check out Ionis Pharmaceuticals Piotroski F Score and Ionis Pharmaceuticals Altman Z Score analysis. For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Ionis Stock analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Ionis Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ionis Pharmaceuticals. If investors know Ionis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ionis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.44) | Earnings Share (2.67) | Revenue Per Share 5.397 | Quarterly Revenue Growth (0.08) | Return On Assets (0.08) |
The market value of Ionis Pharmaceuticals is measured differently than its book value, which is the value of Ionis that is recorded on the company's balance sheet. Investors also form their own opinion of Ionis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ionis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ionis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ionis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ionis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ionis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ionis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.